| Mrs Teresia Mwango Maangi, LVN | |
|
2415 Carson Trl, Grand Prairie, TX 75052-7865 | |
| (817) 602-0174 | |
| Not Available |
| Full Name | Mrs Teresia Mwango Maangi |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 2415 Carson Trl, Grand Prairie, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740763432 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 341862 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Teresia Mwango Maangi, LVN 2415 Carson Trl, Grand Prairie, TX 75052-7865 Ph: (817) 602-0174 | Mrs Teresia Mwango Maangi, LVN 2415 Carson Trl, Grand Prairie, TX 75052-7865 Ph: (817) 602-0174 |
News Archive
Child heart deaths at the Bristol Royal Infirmary have fallen markedly, to below the national average, finds a study in this week's BMJ.
QT Vascular Ltd., together with its subsidiaries (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group"), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, announce today the release of the initial results from the first-in-human study of its unique drug-coated balloon, Chocolate Heart.
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) notified the companies that it will require a three-month extension to complete its review of the data supporting the New Drug Application (NDA) for linaclotide for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC).
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Moores Cancer Center at the University of California San Diego (UCSD) has filed an Investigational New Drug Application with the U.S. Food & Drug Administration ("FDA") for approval to test Nupen, Apricus Bio's proprietary, topical NexACT-based formulation of filgrastim (Neupogen).
The Jan. 17 issue of the Journal of the American Medical Association features an important study about sepsis with an accompanying editorial by a University of Nebraska Medical Center expert.
› Verified 3 days ago
Lise Dorrough, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3249 Cathedral Dr, Grand Prairie, TX 75052 Phone: 214-793-8937 Fax: 972-262-8803 | |
Mrs. Shelly Rose Wilkes, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3103 Parham Dr Apt 227, Grand Prairie, TX 75052 Phone: 817-495-4880 Fax: 214-235-0789 | |
Amanda Azubike, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4593 Mt Laurel Dr, Grand Prairie, TX 75052 Phone: 972-480-1509 | |
Oluwaremilekun Rachel Oluwasegun, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2340 Shirecreek Cir, Grand Prairie, TX 75052 Phone: 651-500-8086 | |
Sunday Omorotiomwan, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2815 Pino, Grand Prairie, TX 75054 Phone: 817-798-0575 | |
Irene Matuto, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1016 Gaines Mills Rd, Grand Prairie, TX 75052 Phone: 469-531-4380 | |
Brittani Presley, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4951 Eyrie Ct, Grand Prairie, TX 75052 Phone: 214-683-0051 |